Releaf Review: Accessing Medical Cannabis in the UK Through a Legitimate Clinic

Medical cannabis has been legally available in the UK since 2018. Most people don't know this - and those who do often have no idea how to access it through the proper clinical pathway or whether they'd qualify.

I've spent time looking into the UK medical cannabis clinic landscape. Releaf is one of the better-established names in this space. Here's what the process actually looks like and who it's genuinely appropriate for.

What Releaf Is

Releaf is a UK-based medical cannabis clinic that operates entirely online. It connects patients with specialist doctors who can legally prescribe cannabis-based medicinal products (CBMPs) where clinically appropriate.

The clinic is not a grey-market operation or a loophole service. It operates within the UK legal framework for medical cannabis prescribing: specialist-prescribed, MHRA-regulated products, dispensed through registered pharmacies. The doctors prescribing through Releaf are GMC-registered specialists.

Who Qualifies

This is the most important question. Medical cannabis in the UK is not available to anyone who wants it - it's available to patients with diagnosed conditions that haven't responded adequately to conventional treatment.

The conditions most commonly treated through UK medical cannabis clinics include:

• Chronic pain (neuropathic pain, musculoskeletal pain not responding to conventional analgesics, fibromyalgia)
• Sleep disorders associated with chronic pain
• Anxiety disorders (where conventional treatments have been inadequate, and CBD-dominant products are typically prescribed)
• PTSD (particularly treatment-resistant)
• MS-related symptoms (spasticity, pain)
• Cancer-related symptoms (pain, nausea, appetite)

The "treatment-resistant" requirement is genuine. Legitimate clinics will not prescribe cannabis to patients who haven't tried conventional treatments. If you have chronic back pain and have only ever taken ibuprofen occasionally, you won't qualify. If you have chronic neuropathic pain that hasn't responded to gabapentin, amitriptyline, or specialist pain management, you're in a different position.

The Releaf Process

Eligibility check: The process starts with an online eligibility questionnaire. This covers your condition, symptoms, duration, diagnoses, and treatments tried. Releaf reviews this and tells you whether you're likely to qualify before charging anything. If you don't meet eligibility criteria, you find out at this stage - no money spent.

Consultation: If you pass the initial screen, you book a video consultation with a specialist doctor. The consultation typically runs 45–60 minutes and covers your full medical history, current condition, previous treatments, and relevant lifestyle factors. The doctor is doing a proper clinical assessment - this isn't a rubber-stamping exercise.

Prescription decision: At the end of the consultation, the doctor decides whether to prescribe. If appropriate, you receive a prescription for specific products at specific doses. The doctor explains the products prescribed, the route of administration (vaporisation, oil, etc.), the dosing schedule, and what to monitor.

Dispensing: The prescription is sent to Releaf's partner pharmacy. Products are dispensed in compliant, discreet packaging and delivered to your home. All products are MHRA-regulated, lab-tested CBMPs - not street cannabis.

Follow-up: Patients are reviewed regularly (typically at 1 month, then 3 months, then every 6 months). Dose and product adjustments are made based on clinical response.

Cost

Initial consultation: approximately £99–149. Monthly prescription costs vary by product type and dose - typically £100–300 per month depending on what's prescribed. These are private costs - NHS medical cannabis prescribing remains limited to specific conditions.

This cost needs to be weighed against: the ongoing cost of other treatments that aren't working, the impact of uncontrolled chronic pain on productivity and quality of life, and the alternative of illegal cannabis use (which carries legal risk, unknown product quality, and no clinical monitoring).

What to Expect From Treatment

For men approaching this with realistic expectations:

Medical cannabis is not a cure. It's a management tool for symptoms that conventional treatments haven't adequately controlled. The research shows meaningful reductions in pain scores, sleep improvement, and quality of life improvement for appropriate patients. It rarely eliminates pain entirely.

Most patients prescribed flower for vaporisation notice effects within the first week. Oils are slower - full effect at steady-state takes 2–4 weeks of consistent use.

Side effects are real and clinically managed. THC-containing products can cause cognitive effects (particularly at higher doses or in new patients), increased heart rate, and anxiety in some users. The clinical team adjusts products and doses to manage tolerability.

For men who are drug-tested: THC will produce positive cannabis screens. This is a significant practical consideration for employment. CBD-dominant prescriptions are lower-risk for drug testing, but disclosure to occupational health is the appropriate approach if on any cannabis medication.

The Alternative to Releaf

For men who have chronic conditions that might qualify, the alternatives are:

NHS pathway: Technically available but extremely limited in practice. Most GPs cannot prescribe. NHS specialist pathways for medical cannabis (other than epilepsy) are inconsistently available across trusts. The practical NHS option for most patients is effectively not accessible.

Self-management with legal CBD: For men with anxiety and mild sleep issues, over-the-counter CBD may provide partial relief. For chronic pain at the level that typically qualifies for medical cannabis prescription, OTC CBD is usually inadequate.

Illegal cannabis: Carries legal risk, unknown product safety, inconsistent potency, and no clinical monitoring. The existence of the legal pathway makes this an unnecessary risk for men in qualifying categories.

Check your eligibility with Releaf →

---

Medical cannabis is a prescription-only medicine in the UK. This article is for informational purposes and does not constitute medical advice. Eligibility assessment is conducted by Releaf's clinical team, not determined by this article.